Cargando…

Cerebral salt wasting in a patient with myeloproliferative neoplasm

BACKGROUND: Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma. The renal function is normal with excretion of very high amounts of sodium in the urine. Diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlik, Lea, Venzin, Reto, Fehr, Thomas, Hohloch, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637491/
https://www.ncbi.nlm.nih.gov/pubmed/31319788
http://dx.doi.org/10.1186/s12883-019-1393-4
_version_ 1783436249843892224
author Orlik, Lea
Venzin, Reto
Fehr, Thomas
Hohloch, Karin
author_facet Orlik, Lea
Venzin, Reto
Fehr, Thomas
Hohloch, Karin
author_sort Orlik, Lea
collection PubMed
description BACKGROUND: Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma. The renal function is normal with excretion of very high amounts of sodium in the urine. Diagnosis is made by excluding other reasons for hyponatremia, mainly the syndrome of inappropriate antidiuretic hormone secretion (SIADH). CASE PRESENTATION: A 60-year-old patient was admitted to the emergency room with pain in the upper abdomen and visual disturbance two weeks after knee replacement. The patient was confused with severe hematoma at the site of the knee endoprosthesis. Laboratory values showed massive thrombocytosis, leukocytosis, anemia, severe hyponatremia and no evidence of infection. CT scan of the abdomen was inconspicuous. Head MRI showed no ischemia or bleeding, but a mild microangiopathy. A myeloproliferative neoplasm (MPN) was suspected and confirmed by bone marrow biopsy. Cerebral salt wasting syndrome was identified as the cause of severe hyponatremia most likely provoked by cerebral microcirculatory disturbance. The hematoma at the operation site was interpreted as a result of a secondary von Willebrand syndrome (vWS) due to the myeloproliferative neoplasm with massive thrombocytosis. After starting cytoreductive therapy with hydroxycarbamide, thrombocytosis and blood sodium slowly improved along with normalization of his mental condition. CONCLUSION: To the best of our knowledge this is the first description of a patient with CSW most likely caused by a microcirculatory disturbance due to a massive thrombocytosis in the context of a myeloproliferative neoplasm.
format Online
Article
Text
id pubmed-6637491
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66374912019-07-25 Cerebral salt wasting in a patient with myeloproliferative neoplasm Orlik, Lea Venzin, Reto Fehr, Thomas Hohloch, Karin BMC Neurol Case Report BACKGROUND: Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma. The renal function is normal with excretion of very high amounts of sodium in the urine. Diagnosis is made by excluding other reasons for hyponatremia, mainly the syndrome of inappropriate antidiuretic hormone secretion (SIADH). CASE PRESENTATION: A 60-year-old patient was admitted to the emergency room with pain in the upper abdomen and visual disturbance two weeks after knee replacement. The patient was confused with severe hematoma at the site of the knee endoprosthesis. Laboratory values showed massive thrombocytosis, leukocytosis, anemia, severe hyponatremia and no evidence of infection. CT scan of the abdomen was inconspicuous. Head MRI showed no ischemia or bleeding, but a mild microangiopathy. A myeloproliferative neoplasm (MPN) was suspected and confirmed by bone marrow biopsy. Cerebral salt wasting syndrome was identified as the cause of severe hyponatremia most likely provoked by cerebral microcirculatory disturbance. The hematoma at the operation site was interpreted as a result of a secondary von Willebrand syndrome (vWS) due to the myeloproliferative neoplasm with massive thrombocytosis. After starting cytoreductive therapy with hydroxycarbamide, thrombocytosis and blood sodium slowly improved along with normalization of his mental condition. CONCLUSION: To the best of our knowledge this is the first description of a patient with CSW most likely caused by a microcirculatory disturbance due to a massive thrombocytosis in the context of a myeloproliferative neoplasm. BioMed Central 2019-07-18 /pmc/articles/PMC6637491/ /pubmed/31319788 http://dx.doi.org/10.1186/s12883-019-1393-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Orlik, Lea
Venzin, Reto
Fehr, Thomas
Hohloch, Karin
Cerebral salt wasting in a patient with myeloproliferative neoplasm
title Cerebral salt wasting in a patient with myeloproliferative neoplasm
title_full Cerebral salt wasting in a patient with myeloproliferative neoplasm
title_fullStr Cerebral salt wasting in a patient with myeloproliferative neoplasm
title_full_unstemmed Cerebral salt wasting in a patient with myeloproliferative neoplasm
title_short Cerebral salt wasting in a patient with myeloproliferative neoplasm
title_sort cerebral salt wasting in a patient with myeloproliferative neoplasm
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637491/
https://www.ncbi.nlm.nih.gov/pubmed/31319788
http://dx.doi.org/10.1186/s12883-019-1393-4
work_keys_str_mv AT orliklea cerebralsaltwastinginapatientwithmyeloproliferativeneoplasm
AT venzinreto cerebralsaltwastinginapatientwithmyeloproliferativeneoplasm
AT fehrthomas cerebralsaltwastinginapatientwithmyeloproliferativeneoplasm
AT hohlochkarin cerebralsaltwastinginapatientwithmyeloproliferativeneoplasm